Zobrazeno 1 - 10
of 182
pro vyhledávání: '"FA Kuypers"'
Publikováno v:
Journal of Lipid Research, Vol 34, Iss 11, Pp 2005-2012 (1993)
Oxidative modification of membrane lipids by hypochlorous acid could be an important element in the mechanism of membrane disruption by activated neutrophils. We have previously shown that hypochlorous acid reacts with unsaturated fatty acids of memb
Externí odkaz:
https://doaj.org/article/d3113b6876a54c47810195de36bd7b19
Publikováno v:
Journal of Lipid Research, Vol 34, Iss 8, Pp 1413-1422 (1993)
This study was designed to determine the effects of a variety of naturally occurring saturated fats on aortic lesion formation in C57BL/6J mice that are susceptible to diet-induced fatty streak lesions. Groups of female mice were randomly assigned to
Externí odkaz:
https://doaj.org/article/5a8d599ec774498ba8e1f097aca2701e
Publikováno v:
Blood. 81:1051-1057
In the human erythrocyte membrane phosphatidylcholine and sphingomyelin reside mainly in the outer leaflet, whereas the aminophospholipids, phosphatidylethanolamine and phosphatidylserine, are mainly found in the inner leaflet. Maintenance of phospho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3af406ca6024b56eb15690cd5fa5fa08
https://doi.org/10.1182/blood.v81.4.1051.bloodjournal8141051
https://doi.org/10.1182/blood.v81.4.1051.bloodjournal8141051
Publikováno v:
Blood. 78(11)
A deficiency of membrane proteins having a glycosylphosphatidylinositol (GPI) anchor is characteristic of the erythrocytes of paroxysmal nocturnal hemoglobinuria (PNH) and is currently believed to be the basis for the enhanced susceptibility to lysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6104d2dd6e2849a3b690ea68d260c9
https://pubmed.ncbi.nlm.nih.gov/1720041
https://pubmed.ncbi.nlm.nih.gov/1720041
Publikováno v:
Blood. 70:1111-1118
The phosphatidylcholine specific transfer protein (PCTP) from bovine liver was used to retailor the molecular species composition of phosphatidylcholine (PC) in the membrane of normal (AA) and sickleable (SS) human erythrocytes. Changes in molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::090b1be7ac33a38b481eadba44c65b71
https://doi.org/10.1182/blood.v70.4.1111.bloodjournal7041111
https://doi.org/10.1182/blood.v70.4.1111.bloodjournal7041111
Publikováno v:
Europe PubMed Central
The phospholipids of the human red cell are distributed asymmetrically in the bilayer of the red cell membrane. In certain pathologic states, such as sickle cell anemia, phospholipid asymmetry is altered. Although several methods can be used to measu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7d46fe1c9d796a5b3eaba14f7f77c8f1
http://europepmc.org/abstract/med/8562945
http://europepmc.org/abstract/med/8562945
Autor:
Ericsson A; Forma Therapeutics, Inc., Watertown, MA., Richard DJ; Forma Therapeutics, Inc., Watertown, MA., Wilker E; Forma Therapeutics, Inc., Watertown, MA., Lancia DR Jr; Forma Therapeutics, Inc., Watertown, MA., Fessler S; Forma Therapeutics, Inc., Watertown, MA., Troccolo P; Forma Therapeutics, Inc., Watertown, MA., Zheng X; Forma Therapeutics, Inc., Watertown, MA., Toms A; Forma Therapeutics, Inc., Watertown, MA., Dinsmore C; Forma Therapeutics, Inc., Watertown, MA., Yao L; Forma Therapeutics, Inc., Watertown, MA., Kuypers FA; University of California San Francisco, Oakland, CA., Larkin S; University of California San Francisco, Oakland, CA., Marcotte D; Forma Therapeutics, Inc., Watertown, MA., Fulzele K; Forma Therapeutics, Inc., Watertown, MA., Ribadeneira M; Forma Therapeutics, Inc., Watertown, MA., Guichard SM; Novo Nordisk, Watertown, MA. Electronic address: sygx@novonordisk.com., Marshall G; Forma Therapeutics, Inc., Watertown, MA.
Publikováno v:
Experimental hematology [Exp Hematol] 2024 Nov 15; Vol. 141, pp. 104673. Date of Electronic Publication: 2024 Nov 15.
Autor:
Saraf SL; Department of Medicine, University of Illinois at Chicago, Chicago, IL., Hagar R; University of California, San Francisco, Benioff Children's Hospital San Francisco, Oakland, CA., Idowu M; Department of Internal Medicine, University of Texas, McGovern Medical School, Houston, TX., Osunkwo I; Levine Cancer Institute, Atrium Health, Charlotte, NC.; Novo Nordisk Rare Disease, Zurich, Switzerland., Cruz K; Advanced Pharma, CR, LLC, Miami, FL., Kuypers FA; Department of Pediatrics, University of California, San Francisco, Oakland, CA., Brown RC; Children's Healthcare of Atlanta, Atlanta, GA., Geib J; Forma Therapeutics, a part of Novo Nordisk, Watertown, MA., Ribadeneira M; Novo Nordisk, Plainsboro, NJ., Schroeder P; Novo Nordisk, Plainsboro, NJ., Wu E; Novo Nordisk, Plainsboro, NJ., Forsyth S; Novo Nordisk, Plainsboro, NJ., Kelly PF; Forma Therapeutics, a part of Novo Nordisk, Watertown, MA., Kalfa TA; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH., Telen MJ; Department of Medicine and Duke Comprehensive Sickle Cell Center, Duke University Medical Center, Durham, NC.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 27; Vol. 8 (16), pp. 4459-4475.
Autor:
Larkin SK; Department of Pediatrics, University of California San Francisco, UCSF RBClab, 5700 MLK Jr. Way, Oakland, CA, 94609, USA. Sandra.Larkin@UCSF.edu., Hernández C; Department Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, 3584 CX, Utrecht, The Netherlands., van Beers EJ; Center for Benign Hematology, Thrombosis and Hemostasis - Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, 3584 CX, Utrecht, The Netherlands., van Wijk R; Department Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, 3584 CX, Utrecht, The Netherlands., Kuypers FA; Department of Pediatrics, University of California San Francisco, UCSF RBClab, 5700 MLK Jr. Way, Oakland, CA, 94609, USA.
Publikováno v:
Scientific reports [Sci Rep] 2024 Mar 15; Vol. 14 (1), pp. 6344. Date of Electronic Publication: 2024 Mar 15.
Autor:
Costello JL; Department of Biosciences, University of Exeter, Exeter, UK. Electronic address: J.Costello@exeter.ac.uk., Koster J; Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, The Netherlands., Silva BSC; Department of Biosciences, University of Exeter, Exeter, UK; Luxembourg Centre for Systems Biomedicine, Campus Belval | House of Biomedicine II, Université du Luxembourg, Belvaux, Luxembourg., Worthy HL; Department of Biosciences, University of Exeter, Exeter, UK., Schrader TA; Department of Biosciences, University of Exeter, Exeter, UK., Hacker C; Department of Biosciences, University of Exeter, Exeter, UK., Passmore J; Department of Biosciences, University of Exeter, Exeter, UK; Division of Cell Biology, Utrecht University, Utrecht, The Netherlands., Kuypers FA; University of California, San Francisco, USA., Waterham HR; Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, The Netherlands. Electronic address: h.r.waterham@amsterdamumc.nl., Schrader M; Department of Biosciences, University of Exeter, Exeter, UK. Electronic address: M.Schrader@exeter.ac.uk.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2023 Aug; Vol. 299 (8), pp. 105013. Date of Electronic Publication: 2023 Jul 04.